IDEAS home Printed from https://ideas.repec.org/a/cai/reidbu/rei_120_0009.html
   My bibliography  Save this article

Délimiter le marché de la santé et faire le droit du vivant. Le rôle des oppositions juridiques aux brevets sur les gènes en Europe

Author

Listed:
  • Maurice Cassier

Abstract

Procedures of legal opposition to patents in Europe are trials which delimit the extension of intellectual property and markets, and which shape the law. In biotechnology and health, the rate of opposition is traditionally higher, and the opponents more heterogeneous, than in other sectors of innovation. Instances of opposition to patents owned by the US company Myriad Genetics are legal precedents as regards life forms and health: they have led to the adoption of stricter criteria for examining patents on gene sequences and to amendments to intellectual property law, especially in France and Belgium. Total or partial revocation of patents on genes and breast cancer gene tests in Europe has limited the extension of private health-care markets and supported the hospital economy and the free use of these genes.

Suggested Citation

  • Maurice Cassier, 2007. "Délimiter le marché de la santé et faire le droit du vivant. Le rôle des oppositions juridiques aux brevets sur les gènes en Europe," Revue d'économie industrielle, De Boeck Université, vol. 0(4), pages 9-9.
    • Handle: RePEc:cai:reidbu:rei_120_0009
    as

    Download full text from publisher

    File URL: http://www.cairn.info/load_pdf.php?ID_ARTICLE=REI_120_0009
    Download Restriction: free
    File URL: http://www.cairn.info/revue-d-economie-industrielle-2007-4-page-9.htm
    Download Restriction: free
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Christian Bessy, 2019. "The transformations of conventions for patent use and the role of legal intermediaries," Working Papers halshs-01872163, HAL.
    2. Fabienne Orsi & Jean-Benoît Zimmermann, 2011. "Propriété intellectuelle et globalisation: des TRIPS au modèle open-source. Les exemples des médicaments et du logiciel," Working Papers halshs-00561477, HAL.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:cai:reidbu:rei_120_0009. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Jean-Baptiste de Vathaire (email available below). General contact details of provider: https://www.cairn.info/revue-d-economie-industrielle.htm .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.